Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Omics Lab Services Market, by Business
1.4.2 Europe Omics Lab Services Market, by End-Use
1.4.3 Europe Omics Lab Services Market, by Type
1.4.4 Europe Omics Lab Services Market, by Product
1.4.5 Europe Omics Lab Services Market, by Frequency of Service
1.4.6 Europe Omics Lab Services Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Omics Lab Services Market
Chapter 4. Europe Omics Lab Services Market by Business
4.1 Europe Diagnostic Labs Market by Country
4.2 Europe Research Institutes Market by Country
4.3 Europe Hospitals Market by Country
Chapter 5. Europe Omics Lab Services Market by End-Use
5.1 Europe Cancer Market by Country
5.2 Europe Pharmaco Market by Country
5.3 Europe Population Studies & Genealogy Market by Country
5.4 Europe Reproductive Market by Country
5.5 Europe Skincare Market by Country
5.6 Europe Nutrition, Vitamin & Supplements Market by Country
5.7 Europe Forensics & Others Market by Country
Chapter 6. Europe Omics Lab Services Market by Type
6.1 Europe Proteomics Market by Country
6.2 Europe Transcriptomic Market by Country
6.3 Europe Metabolomics Market by Country
6.4 Europe Genomics Market by Country
6.5 Europe Epigenetics Market by Country
Chapter 7. Europe Omics Lab Services Market by Product
7.1 Europe Hardware Equipment Market by Country
7.2 Europe Testing / Lab Services Market by Country
7.3 Europe Analytics / Interpretation Market by Country
Chapter 8. Europe Omics Lab Services Market by Frequency of Service
8.1 Europe Continuous Market by Country
8.2 Europe Repeat Market by Country
8.3 Europe One-off Market by Country
Chapter 9. Europe Omics Lab Services Market by Country
9.1 Germany Omics Lab Services Market
9.1.1 Germany Omics Lab Services Market by Business
9.1.2 Germany Omics Lab Services Market by End-Use
9.1.3 Germany Omics Lab Services Market by Type
9.1.4 Germany Omics Lab Services Market by Product
9.1.5 Germany Omics Lab Services Market by Frequency of Service
9.2 UK Omics Lab Services Market
9.2.1 UK Omics Lab Services Market by Business
9.2.2 UK Omics Lab Services Market by End-Use
9.2.3 UK Omics Lab Services Market by Type
9.2.4 UK Omics Lab Services Market by Product
9.2.5 UK Omics Lab Services Market by Frequency of Service
9.3 France Omics Lab Services Market
9.3.1 France Omics Lab Services Market by Business
9.3.2 France Omics Lab Services Market by End-Use
9.3.3 France Omics Lab Services Market by Type
9.3.4 France Omics Lab Services Market by Product
9.3.5 France Omics Lab Services Market by Frequency of Service
9.4 Russia Omics Lab Services Market
9.4.1 Russia Omics Lab Services Market by Business
9.4.2 Russia Omics Lab Services Market by End-Use
9.4.3 Russia Omics Lab Services Market by Type
9.4.4 Russia Omics Lab Services Market by Product
9.4.5 Russia Omics Lab Services Market by Frequency of Service
9.5 Spain Omics Lab Services Market
9.5.1 Spain Omics Lab Services Market by Business
9.5.2 Spain Omics Lab Services Market by End-Use
9.5.3 Spain Omics Lab Services Market by Type
9.5.4 Spain Omics Lab Services Market by Product
9.5.5 Spain Omics Lab Services Market by Frequency of Service
9.6 Italy Omics Lab Services Market
9.6.1 Italy Omics Lab Services Market by Business
9.6.2 Italy Omics Lab Services Market by End-Use
9.6.3 Italy Omics Lab Services Market by Type
9.6.4 Italy Omics Lab Services Market by Product
9.6.5 Italy Omics Lab Services Market by Frequency of Service
9.7 Rest of Europe Omics Lab Services Market
9.7.1 Rest of Europe Omics Lab Services Market by Business
9.7.2 Rest of Europe Omics Lab Services Market by End-Use
9.7.3 Rest of Europe Omics Lab Services Market by Type
9.7.4 Rest of Europe Omics Lab Services Market by Product
9.7.5 Rest of Europe Omics Lab Services Market by Frequency of Service
Chapter 10. Company Profiles
10.1 Thermo Fisher Scientific, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 SWOT Analysis
10.2 Agilent Technologies, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Acquisition and Mergers:
10.3 Qiagen N.V.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Acquisition and Mergers:
10.4 Quest Diagnostics Incorporated
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental Analysis
10.4.4 Recent strategies and developments:
10.4.4.1 Acquisition and Mergers:
10.5 Illumina, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.6 BGI Group
10.6.1 Company Overview
10.7 Q2 Solutions (IQVIA)
10.7.1 Company Overview
10.7.2 Recent strategies and developments:
10.7.2.1 Partnerships, Collaborations, and Agreements:
10.8 Flomics Biotech
10.8.1 Company Overview
10.9 PhenoSwitch Bioscience
10.9.1 Company Overview
10.9.2 Recent strategies and developments:
10.9.2.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 